20-Hydroxyeicosatetraenoic Acid Ameliorates Nickel Nanoparticle-Induced Epithelial-Mesenchymal Transition by Modulating the FFAR1/NF-kB Pathway
Nickel nanoparticles (Nano-Ni) are widely utilized in industrial and biomedical applications due to their unique physicochemical properties. However, their expanded usage increases risks of occupational and environmental exposure. In this study, we established a mouse exposure model via single intratracheal instillation of Nano-Ni and analyzed the perturbation characteristics of lung tissue metabolic profiles using untargeted metabolomics. Subsequently, the biological function of the key metabolite 20-hydroxyeicosatetraenoic acid (20-HETE) was explored in Nano-Ni-exposed lung epithelial cells to elucidate the underlying mechanisms of metabolic alterations in Nano-Ni-induced pulmonary fibrosis. Our results showed that exposure to Nano-Ni induced marked alveolar architecture destruction, interstitial thickening, and upregulated expression of fibrotic markers in mouse lung tissues. Metabolomics identified arachidonic acid metabolism as the most disrupted pathway, with 20-HETE exhibiting the most pronounced downregulation. In both BEAS-2B and A549 cell lines, exogenous 20-HETE supplementation significantly attenuated Nano-Ni-induced epithelial-mesenchymal transition (EMT). Furthermore, Nano-Ni exposure reduced mRNA and protein levels of free fatty acid receptor 1 (FFAR1) both in vivo and in vitro. Pretreatment with the FFAR1 agonist GW9508 mitigated Nano-Ni-induced EMT and the activation of NF-κB signaling pathway in both cell lines. Critically, FFAR1 inhibition largely abolished the suppressive effects of 20-HETE on EMT and NF-κB signaling. Altogether, our study suggests that 20-HETE may affect the EMT process in lung epithelial cells at least in part through regulating the FFAR1/NF-κB pathway, thereby potentially contributing to the process of Nano-Ni-induced lung fibrosis. These findings point to a possible role of specific metabolites in Nano-Ni-induced pulmonary fibrosis and may provide novel mechanistic insights into the inhalation toxicity of nanomaterials.
Authors
- Qunwei Zhang (ORCID: https://orcid.org/0000-0001-8609-9192)
- Yiqun Mo (ORCID: https://orcid.org/0000-0003-2598-9268)
- Zhenyao Huang
- Shuai Zhang (ORCID: https://orcid.org/0000-0002-7876-5578)
- Zhenyu Yan
- Huihui Yang
- Jiali Yuan
- Jing Li
Institutions
- Xuzhou Medical College (CN)
- Center for Human Genetics (US)
- Institute of Human Genetics (PL)
- University of Louisville Hospital (US)
Publication Details
- Journal
- Chemical Research in Toxicology
- Published
- 2026-06-18
- DOI
- https://doi.org/10.1021/acs.chemrestox.6c00048
- Primary Topic
- Eicosanoids and Hypertension Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 0.00